This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Ivo Rogulia Siemens: Pioneering Innovation in Smooth Muscle Cell Research
Introduction
Ivo Rogulia Siemens, an inventor based in the United States, has made significant contributions to the field of biomedical research. His work has the potential to impact various therapeutic applications through a deeper understanding of smooth muscle cells.
Latest Patents
Siemens holds a notable patent titled "Smooth muscle cell-derived migration factor." This patent encompasses an isolated nucleic acid encoding the human smooth muscle cell-derived migration factor, a protein obtainable from the nucleic acid, recombinant host cells transformed with this nucleic acid, and the potential uses of the protein and nucleic acid sequence. This innovation lays the groundwork for exploring novel treatments and advancements in medical research.
Career Highlights
With a focus on biotechnology and cell biology, Siemens has dedicated his professional career to innovating and developing tools that enhance the understanding of cell mechanisms. His contributions are crucial in paving the way for future medical breakthroughs, particularly in understanding the behavior of smooth muscle cells.
Collaborations
Throughout his career, Ivo Siemens has collaborated with esteemed colleagues such as Mark Robert Hurle and Peter C McDonnell. These partnerships have fostered a productive research environment, enhancing the scope and impact of their innovations in the scientific community.
Conclusion
Ivo Rogulia Siemens stands out as an accomplished inventor, with a patent that signifies a leap forward in our understanding of smooth muscle cells. His collaboration with other experts further amplifies his contributions, ensuring a lasting legacy in the field of biomedical research. As innovations continue to emerge from such dedicated work, the potential for improved medical treatments grows, benefiting future generations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile